Seno welcomes scientific opportunities to explore application of its patents in direct development, strategic partnering or licensing agreements. More than $13 million has been contributed by nationally recognized institutions as the National Institutes of Health (NIH), the National Cancer Institute (NCI) and the Department of Defense/Department of the Army (DoD) to develop the technology and produce the initial functioning pre-prototypes.
|
|
Seno’s management team has extensive experience in the commercialization of medical device products. This team has been selected based upon their experience in development in imaging, manufacturing and regulatory hurdles in commercialization.
|
|
Read more...
|
|
